Arnold Lippa
CIK 1363763 · Exec. Chairman & CSO · last filed 2021-05-20
Arnold Lippa is an Exec. Chairman & CSO who has filed 22 SEC Form 4 insider transactions across 2 companies since 2016. The most recent filing, for HEPA, was dated May 20, 2021.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
2
22
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| HEPA | Director | — | $0.08 | — | $0 | 4 | 2021-05-20 |
| Hepion Pharmaceuticals, Inc. (CTRV) Delisted | Director | — | — | — | $0 | 2 | 2018-07-03 |
Recent Filings
22 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-05-20 | HEPA | Grant (A) | — | $0 | EDGAR |
| 2020-10-02 | — | Mixed | — | $0 | |
| 2020-08-21 | HEPA | Grant (A) | — | $0 | EDGAR |
| 2020-07-15 | — | Mixed | — | $0 | |
| 2020-04-07 | HEPA | Grant (A) | — | $0 | EDGAR |
| 2020-03-24 | — | Mixed | — | $0 | |
| 2019-07-25 | HEPA | Grant (A) | — | $0 | EDGAR |
| 2018-09-14 | — | Mixed | — | $0 | |
| 2018-07-03 | Hepion Pharmaceuticals, Inc. (CTRV) Delisted | Buy (P) | — | $0 | EDGAR |
| 2017-12-12 | — | Mixed | — | $0 |